Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Patients with Gout May Be More Likely to Develop Osteoporosis

Scott Baltic  |  February 16, 2018

NEW YORK (Reuters Health)—People with gout face a modestly increased risk, of about 20%, for developing osteoporosis, compared to people without gout, researchers in Taiwan suggest.

In their population-based study to examine a possible association between gout and subsequent osteoporosis, Dr. Victor C. Kok of Asia University (Taiwan), Taichung, and colleagues retrospectively analyzed data from a random sample of 1 million people age 20 or older from Taiwan’s Longitudinal Health Insurance Dataset. The new research extends the existing evidence base, which had only focused on osteoporotic fractures in people with gout.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In all, 36,458 patients identified as having gout were matched with a comparison cohort of 71,602 without gout. The mean age of the cohort was about 52 years; 73% were men.

Compared to people without gout, those with gout had significantly higher baseline rates of morbid obesity, smoking-related diagnosis, alcohol use disorder, hypertension, dyslipidemia, diabetes, kidney disease, and rheumatoid arthritis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Follow-up lasted up to eight years, but to avoid bias, the study excluded osteoporotic outcomes in the first three years of follow-up.

In all, 517 participants in the gout cohort and 811 in the non-gout cohort were diagnosed with osteoporosis by a physician. In a multivariable-adjusted Cox model, gout was associated with a significantly greater hazard ratio for incident osteoporosis (HR, 1.2; 95% confidence interval, 1.06-1.35). However, the HR was statistically significant only for men with gout, not for women with gout.

Risk for incident osteoporosis also was associated with increasing age in the gout cohort, as it was with alcohol use disorder, dyslipidemia, and glucocorticoid steroid use at least 135-mg hydrocortisone equivalent, according to the January 30 Osteoporosis International online report.

Dr. Kok told Reuters Health by email that until further research confirms the results, “clinicians can initiate interventions for patients with gout to tackle the issues of osteoporosis screening and fracture prevention based on a discussion of patient preferences, fracture risk profile, and benefits, harms, and costs of medications.”

However, Dr. Howard L. Feinberg, of Touro University, Vallejo, California, told Reuters Health by email that this study’s findings are at odds with those of a 2015 study from China, which found that higher uric acid (as seen in gout) was associated with higher bone mineral density (less osteoporosis).

Dr. Feinberg also noted that although using insurance claims data allows researchers to look at a large population, “there are always errors in the information when it is obtained this way.” Osteoporosis risk also varies by race and nationality, he cautioned.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsGout and Crystalline ArthritisOsteoarthritis and Bone Disorders Tagged with:GoutOsteoporosisVictor C. Kok

Related Articles

    Gout Research at a Glance: ‘My picks for the top research in gout presented at ACR Convergence 2021’

    November 10, 2021

    Dr. Lisa Stamp helps filter the noise to get to the key insights from the research abstracts on gout presented at ACR Convergence 2021.

    Gout, Glucose Metabolism and Obesity: A Case Review

    November 2, 2014

    New research explores association between hyperurecimia and gout with metabolic derangement

    New Gout Criteria from the ACR/EULAR Focus on Clinical Trials, Global Standards

    November 17, 2015

    Gout affects nearly 4% of American adults, causing joint inflammation, pain and crystal deposits that may lead to bone erosion over time. At least five different classification criteria for gout are used worldwide, creating potential discrepancies in clinical trial enrollment and eventual results. An international panel of investigators collaborated to create new, standardized gout classification…

    Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4

    October 14, 2019

    Three clinical experts on gout offer their insights into common management errors, clinical pearls, new safety data from the FDA and the role of biologic therapies in the management of gout.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences